Aeterna Zentaris Inc. announced the appointment of Leslie Auld as Senior Vice President, Chief Financial Officer. Ms. Auld has over twenty-five years of accounting, finance and pharmaceutical industry experience, with increasingly senior roles at PricewaterhouseCoopers, Helix BioPharma Corp., Luminex Diagnostics (formerly TM BioScience Corp.), Attwell Capital Inc. (formerly Fralex Therapeutics) and GeneNews Limited. Auld is replacing James Clavijo, who is leaving Aeterna Zentaris to pursue other interests.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13 CAD | -2.11% | +11.21% | +26.46% |
29/05 | Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger | MT |
17/05 | Aeterna Zentaris Finalizes Some Details for Ceapro Merger | MT |
1st Jan change | Capi. | |
---|---|---|
+26.46% | 11.57M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.15% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- AEZS Stock
- News Aeterna Zentaris Inc.
- Aeterna Zentaris Inc. Announces Management Changes